{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T01:49:13Z","timestamp":1789955353463,"version":"4.0.1"},"reference-count":46,"publisher":"The Endocrine Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Recent years have seen an increased focus on human islet biology, and exciting findings in the stem cell and genomic arenas highlight the need to define the key features of mature human islets and \u03b2-cells. Donor and organ procurement parameters impact human islet yield, although for research purposes islet yield may be secondary in importance to islet function. We examined the feasibility of a research-only human islet isolation, distribution, and biobanking program and whether key criteria such as cold ischemia time (CIT) and metabolic status may be relaxed and still allow successful research-focused isolations, including from donors with type 1 diabetes and type 2 diabetes. Through 142 isolations over approximately 5 years, we confirm that CIT and glycated hemoglobin each have a weak negative impacts on isolation purity and yield, and extending CIT beyond the typical clinical isolation cutoff of 12 hours (to \u2265 18 h) had only a modest impact on islet function. Age and glycated hemoglobin\/type 2 diabetes status negatively impacted secretory function; however, these and other biological (sex, body mass index) and procurement\/isolation variables (CIT, time in culture) appear to make only a small contribution to the heterogeneity of human islet function. This work demonstrates the feasibility of extending acceptable CIT for research-focused human islet isolation and highlights the biological variation in function of human islets from donors with and without diabetes.<\/jats:p>","DOI":"10.1210\/en.2015-1562","type":"journal-article","created":{"date-parts":[[2015,12,11]],"date-time":"2015-12-11T13:00:42Z","timestamp":1449838842000},"page":"560-569","source":"Crossref","is-referenced-by-count":141,"title":["Research-Focused Isolation of Human Islets From Donors With and Without Diabetes at the Alberta Diabetes Institute IsletCore"],"prefix":"10.1210","volume":"157","author":[{"given":"James","family":"Lyon","sequence":"first","affiliation":[{"name":"Alberta Diabetes Institute IsletCore (J.L., J.E.M.F., P.E.M.) University of Alberta, Edmonton, Canada T6G 2E1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelyn E.","family":"Manning Fox","sequence":"first","affiliation":[{"name":"Alberta Diabetes Institute IsletCore (J.L., J.E.M.F., P.E.M.) University of Alberta, Edmonton, Canada T6G 2E1"},{"name":"Departments of Pharmacology (J.E.M.F., A.F.S., R.K., N.S., P.E.M.) University of Alberta, Edmonton, Canada T6G 2E1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliya F.","family":"Spigelman","sequence":"first","affiliation":[{"name":"Departments of Pharmacology (J.E.M.F., A.F.S., R.K., N.S., P.E.M.) University of Alberta, Edmonton, Canada T6G 2E1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryekjang","family":"Kim","sequence":"first","affiliation":[{"name":"Alberta Diabetes Institute IsletCore (J.L., J.E.M.F., P.E.M.) University of Alberta, Edmonton, Canada T6G 2E1"},{"name":"Departments of Pharmacology (J.E.M.F., A.F.S., R.K., N.S., P.E.M.) University of Alberta, Edmonton, Canada T6G 2E1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Smith","sequence":"first","affiliation":[{"name":"Departments of Pharmacology (J.E.M.F., A.F.S., R.K., N.S., P.E.M.) University of Alberta, Edmonton, Canada T6G 2E1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doug","family":"O'Gorman","sequence":"first","affiliation":[{"name":"Surgery (D.O., T.K., A.M.J.S., R.V.R.), University of Alberta, Edmonton, Canada T6G 2E1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Kin","sequence":"first","affiliation":[{"name":"Surgery (D.O., T.K., A.M.J.S., R.V.R.), University of Alberta, Edmonton, Canada T6G 2E1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. M. James","family":"Shapiro","sequence":"first","affiliation":[{"name":"Surgery (D.O., T.K., A.M.J.S., R.V.R.), University of Alberta, Edmonton, Canada T6G 2E1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond V.","family":"Rajotte","sequence":"first","affiliation":[{"name":"Surgery (D.O., T.K., A.M.J.S., R.V.R.), University of Alberta, Edmonton, Canada T6G 2E1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick E.","family":"MacDonald","sequence":"first","affiliation":[{"name":"Alberta Diabetes Institute IsletCore (J.L., J.E.M.F., P.E.M.) University of Alberta, Edmonton, Canada T6G 2E1"},{"name":"Departments of Pharmacology (J.E.M.F., A.F.S., R.K., N.S., P.E.M.) University of Alberta, Edmonton, Canada T6G 2E1"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2015,12,11]]},"reference":[{"issue":"5","key":"2020071612210410300_B1","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1007\/s00125-015-3536-5","article-title":"Human islet distribution programme for basic research: activity over the last 5 years","volume":"58","author":"Nano","year":"2015","journal-title":"Diabetologia"},{"issue":"9","key":"2020071612210410300_B2","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1016\/j.transproceed.2011.10.003","article-title":"Human islet distribution program for basic research at a single center","volume":"43","author":"Kin","year":"2011","journal-title":"Transplant Proc"},{"issue":"15","key":"2020071612210410300_B3","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1001\/jama.2009.482","article-title":"Human pancreatic islets and diabetes research","volume":"301","author":"Kaddis","year":"2009","journal-title":"JAMA"},{"issue":"3","key":"2020071612210410300_B4","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/j.1600-6143.2009.02962.x","article-title":"Multicenter analysis of novel and established variables associated with successful human islet isolation outcomes","volume":"10","author":"Kaddis","year":"2010","journal-title":"Am J Transplant"},{"issue":"7","key":"2020071612210410300_B5","doi-asserted-by":"crossref","first-page":"E592","DOI":"10.1152\/ajpendo.00437.2014","article-title":"Human islet preparations distributed for research exhibit a variety of insulin-secretory profiles","volume":"308","author":"Kayton","year":"2015","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"5","key":"2020071612210410300_B6","doi-asserted-by":"crossref","first-page":"265","DOI":"10.4161\/isl.2.5.13019","article-title":"Surgical aspects of human islet isolation","volume":"2","author":"Kin","year":"2010","journal-title":"Islets"},{"issue":"7","key":"2020071612210410300_B7","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1007\/s00125-015-3598-4","article-title":"Human islet function following 20 years of cryogenic biobanking","volume":"58","author":"Manning Fox","year":"2015","journal-title":"Diabetologia"},{"issue":"12","key":"2020071612210410300_B8","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.2337\/db14-1303","article-title":"Summary of the keystone islet workshop (April 2014): the increasing demand for human islet availability in diabetes research","volume":"63","author":"Kulkarni","year":"2014","journal-title":"Diabetes"},{"key":"2020071612210410300_B9","first-page":"72","article-title":"Islet cryopreservation","volume":"25","author":"Rajotte","year":"1990","journal-title":"Horm Metab Res Suppl"},{"issue":"8","key":"2020071612210410300_B10","doi-asserted-by":"crossref","first-page":"921","DOI":"10.3727\/096368913X666412","article-title":"Effects of donor-, pancreas-, and isolation-related variables on human islet isolation outcome: a systematic review","volume":"23","author":"Hilling","year":"2014","journal-title":"Cell Transplant"},{"issue":"6","key":"2020071612210410300_B11","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1016\/j.transproceed.2010.05.099","article-title":"Islet isolation from human pancreas with extended cold ischemia time","volume":"42","author":"K\u00fchtreiber","year":"2010","journal-title":"Transplant Proc"},{"key":"2020071612210410300_B12","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/978-90-481-3271-3_30","article-title":"Islet isolation for clinical transplantation","volume":"654","author":"Kin","year":"2010","journal-title":"Adv Exp Med Biol"},{"issue":"10","key":"2020071612210410300_B13","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1172\/JCI82498","article-title":"Isocitrate-to-SENP1 signaling amplifies insulin secretion and rescues dysfunctional \u03b2 cells","volume":"125","author":"Ferdaoussi","year":"2015","journal-title":"J Clin Invest"},{"issue":"4","key":"2020071612210410300_B14","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1210\/en.2012-1934","article-title":"Functional plasticity of the human infant \u03b2-cell exocytotic phenotype","volume":"154","author":"Manning Fox","year":"2013","journal-title":"Endocrinology"},{"key":"2020071612210410300_B15","doi-asserted-by":"crossref","first-page":"S160","DOI":"10.2337\/diabetes.50.2007.S160","article-title":"\u03b2-Cell dysfunction and failure in type 2 diabetes: potential mechanisms","volume":"50","author":"Porte","year":"2001","journal-title":"Diabetes"},{"issue":"9922","key":"2020071612210410300_B16","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S0140-6736(13)62154-6","article-title":"Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future","volume":"383","author":"Kahn","year":"2014","journal-title":"Lancet"},{"issue":"11","key":"2020071612210410300_B17","doi-asserted-by":"crossref","first-page":"5535","DOI":"10.1210\/jc.2004-0150","article-title":"Pancreatic islets from type 2 diabetic patients have functional defects and increased apoptosis that are ameliorated by metformin","volume":"89","author":"Marchetti","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612210410300_B18","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/978-90-481-3271-3_22","article-title":"The \u03b2-cell in human type 2 diabetes","volume":"654","author":"Marchetti","year":"2010","journal-title":"Adv Exp Med Biol"},{"issue":"5","key":"2020071612210410300_B19","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.diabet.2007.03.005","article-title":"Insulin secretion defects of human type 2 diabetic islets are corrected in vitro by a new reactive oxygen species scavenger","volume":"33","author":"Lupi","year":"2007","journal-title":"Diabetes Metab"},{"issue":"1","key":"2020071612210410300_B20","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s00125-010-1930-6","article-title":"Glucose-responsive \u03b2 cells in islets isolated from a patient with long-standing type 1 diabetes mellitus","volume":"54","author":"Walker","year":"2011","journal-title":"Diabetologia"},{"issue":"5","key":"2020071612210410300_B21","doi-asserted-by":"crossref","first-page":"701","DOI":"10.2337\/diacare.23.5.701","article-title":"Function of pancreatic islets isolated from a type 1 diabetic patient","volume":"23","author":"Marchetti","year":"2000","journal-title":"Diabetes Care"},{"issue":"7","key":"2020071612210410300_B22","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.2337\/db14-1911","article-title":"Function of isolated pancreatic islets from patients at onset of type 1 diabetes; Insulin secretion can be restored after some days in a non-diabetogenic environment in vitro. Results from the DiViD study","volume":"64","author":"Krogvold","year":"2015","journal-title":"Diabetes"},{"issue":"4","key":"2020071612210410300_B23","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.stemcr.2015.02.011","article-title":"Treating diet-induced diabetes and obesity with human embryonic stem cell-derived pancreatic progenitor cells and antidiabetic drugs","volume":"4","author":"Bruin","year":"2015","journal-title":"Stem Cell Reports"},{"issue":"11","key":"2020071612210410300_B24","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/nbt.3033","article-title":"Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells","volume":"32","author":"Rezania","year":"2014","journal-title":"Nat Biotechnol"},{"issue":"2","key":"2020071612210410300_B25","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.cell.2014.09.040","article-title":"Generation of functional human pancreatic \u03b2 cells in vitro","volume":"159","author":"Pagliuca","year":"2014","journal-title":"Cell"},{"issue":"38","key":"2020071612210410300_B26","doi-asserted-by":"crossref","first-page":"13924","DOI":"10.1073\/pnas.1402665111","article-title":"Global genomic and transcriptomic analysis of human pancreatic islets reveals novel genes influencing glucose metabolism","volume":"111","author":"Fadista","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"2020071612210410300_B27","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1093\/hmg\/ddu610","article-title":"Identification of novel genes for glucose metabolism based upon expression pattern in human islets and effect on insulin secretion and glycemia","volume":"24","author":"Taneera","year":"2015","journal-title":"Hum Mol Genet"},{"issue":"4","key":"2020071612210410300_B28","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nm.3820","article-title":"A high-throughput chemical screen reveals that harmine-mediated inhibition of DYRK1A increases human pancreatic \u03b2 cell replication","volume":"21","author":"Wang","year":"2015","journal-title":"Nat Med"},{"issue":"2","key":"2020071612210410300_B29","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.celrep.2013.01.007","article-title":"Liver-derived systemic factors drive \u03b2 cell hyperplasia in insulin-resistant states","volume":"3","author":"El Ouaamari","year":"2013","journal-title":"Cell Rep"},{"issue":"7","key":"2020071612210410300_B30","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1073\/pnas.0510790103","article-title":"The unique cytoarchitecture of human pancreatic islets has implications for islet cell function","volume":"103","author":"Cabrera","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"2020071612210410300_B31","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.cmet.2011.05.008","article-title":"Innervation patterns of autonomic axons in the human endocrine pancreas","volume":"14","author":"Rodriguez-Diaz","year":"2011","journal-title":"Cell Metab"},{"issue":"8","key":"2020071612210410300_B32","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.2337\/db13-1371","article-title":"Control of insulin secretion by cholinergic signaling in the human pancreatic islet","volume":"63","author":"Molina","year":"2014","journal-title":"Diabetes"},{"issue":"6","key":"2020071612210410300_B33","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.2337\/db07-0991","article-title":"Voltage-gated ion channels in human pancreatic beta-cells: electrophysiological characterization and role in insulin secretion","volume":"57","author":"Braun","year":"2008","journal-title":"Diabetes"},{"issue":"5","key":"2020071612210410300_B34","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.molmet.2015.02.004","article-title":"Munc18c mediates exocytosis of pre-docked and newcomer insulin granules underlying biphasic glucose stimulated insulin secretion in human pancreatic \u03b2-cells","volume":"4","author":"Zhu","year":"2015","journal-title":"Mol Metab"},{"issue":"6","key":"2020071612210410300_B35","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1007\/s00125-015-3545-4","article-title":"Syntaxin-4 mediates exocytosis of pre-docked and newcomer insulin granules underlying biphasic glucose-stimulated insulin secretion in human pancreatic \u03b2 cells","volume":"58","author":"Xie","year":"2015","journal-title":"Diabetologia"},{"issue":"5","key":"2020071612210410300_B36","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s00125-015-3507-x","article-title":"SOX4 cooperates with neurogenin 3 to regulate endocrine pancreas formation in mouse models","volume":"58","author":"Xu","year":"2015","journal-title":"Diabetologia"},{"issue":"4","key":"2020071612210410300_B37","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.cmet.2014.03.008","article-title":"The furan fatty acid metabolite CMPF is elevated in diabetes and induces \u03b2 cell dysfunction","volume":"19","author":"Prentice","year":"2014","journal-title":"Cell Metab"},{"issue":"1\u20132","key":"2020071612210410300_B38","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.mce.2012.08.009","article-title":"Reduced insulin secretion correlates with decreased expression of exocytotic genes in pancreatic islets from patients with type 2 diabetes","volume":"364","author":"Andersson","year":"2012","journal-title":"Mol Cell Endocrinol"},{"issue":"3","key":"2020071612210410300_B39","doi-asserted-by":"crossref","first-page":"727","DOI":"10.2337\/diabetes.54.3.727","article-title":"Functional and molecular defects of pancreatic islets in human type 2 diabetes","volume":"54","author":"Del Guerra","year":"2005","journal-title":"Diabetes"},{"issue":"3","key":"2020071612210410300_B40","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.cell.2005.05.027","article-title":"Loss of ARNT\/HIF1\u03b2 mediates altered gene expression and pancreatic-islet dysfunction in human type 2 diabetes","volume":"122","author":"Gunton","year":"2005","journal-title":"Cell"},{"issue":"1\u20132","key":"2020071612210410300_B41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mce.2012.12.001","article-title":"Microarray analysis of isolated human islet transcriptome in type 2 diabetes and the role of the ubiquitin-proteasome system in pancreatic \u03b2 cell dysfunction","volume":"367","author":"Bugliani","year":"2013","journal-title":"Mol Cell Endocrinol"},{"issue":"3","key":"2020071612210410300_B42","doi-asserted-by":"crossref","first-page":"624","DOI":"10.2337\/diabetes.53.3.624","article-title":"Structural and functional abnormalities in the islets isolated from type 2 diabetic subjects","volume":"53","author":"Deng","year":"2004","journal-title":"Diabetes"},{"issue":"4","key":"2020071612210410300_B43","doi-asserted-by":"crossref","first-page":"988","DOI":"10.2337\/diabetes.51.4.988","article-title":"Pulsatile insulin release from islets isolated from three subjects with type 2 diabetes","volume":"51","author":"Lin","year":"2002","journal-title":"Diabetes"},{"issue":"6","key":"2020071612210410300_B44","doi-asserted-by":"crossref","first-page":"979","DOI":"10.2337\/dc15-0144","article-title":"Current concepts on the pathogenesis of type 1 diabetes-considerations for attempts to prevent and reverse the disease","volume":"38","author":"Atkinson","year":"2015","journal-title":"Diabetes Care"},{"issue":"3","key":"2020071612210410300_B45","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/dmrr.460","article-title":"Improved insulin secretory function and reduced chemotactic properties after tissue culture of islets from type 1 diabetic patients","volume":"20","author":"Lupi","year":"2004","journal-title":"Diabetes Metab Res Rev"},{"issue":"1","key":"2020071612210410300_B46","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1365-2249.2009.04053.x","article-title":"Gene expression profiles for the human pancreas and purified islets in type 1 diabetes: new findings at clinical onset and in long-standing diabetes","volume":"159","author":"Planas","year":"2010","journal-title":"Clin Exp Immunol"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/157\/2\/560\/8993341\/endo0560.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/157\/2\/560\/8993341\/endo0560.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T15:57:50Z","timestamp":1594915070000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/157\/2\/560\/2422624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,11]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2,1]]}},"URL":"https:\/\/doi.org\/10.1210\/en.2015-1562","relation":{},"ISSN":["0013-7227","1945-7170"],"issn-type":[{"value":"0013-7227","type":"print"},{"value":"1945-7170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,11]]}}}